Results
1
-
10
of
116
<
1
2
3
...
11
12
>
Edginton AN; Ahr G; Willmann S; Stass H.
Defining the role of macrophages in local moxifloxacin tissue concentrations using biopsy data and whole-body physiologically based pharmacokinetic modelling.
,
Clinical pharmacokinetics
[PubMed: 19385711]
[DOI: 10.2165/00003088-200948030-000]
Stepanovi?-Petrovi? R; Micov A; Tomi? M; Pecikoza U.
Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.
,
Psychopharmacology
[PubMed: 28332005]
[DOI: 10.1007/s00213-017-4583-z]
Kim SC; Landon JE; Lee YC.
Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia.
,
Arthritis research & therapy
[PubMed: 25627453]
[DOI: 10.1186/s13075-015-0530-8]
Quilici S; Chancellor J; L?thgren M; Simon D; Said G; Le TK; Garcia-Cebrian A; Monz B.
Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.
,
BMC neurology
[PubMed: 19208243]
[DOI: 10.1186/1471-2377-9-6]
Lee YH; Song GG.
Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials.
,
Rheumatology international
[PubMed: 27000046]
[DOI: 10.1007/s00296-016-3468-5]
Ellis JJ; Sadosky AB; Ten Eyck LL; Mudumby P; Cappelleri JC; Ndehi L; Suehs BT; Parsons B.
A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine.
,
BMC health services research
[PubMed: 25889173]
[DOI: 10.1186/s12913-015-0829-9]
Lin ND; Norman H; Regev A; Perahia DG; Li H; Chang CL; Dore DD.
Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database.
,
BMC gastroenterology
[PubMed: 26467777]
[DOI: 10.1186/s12876-015-0373-4]
Ye W; Zhao Y; Robinson RL; Swindle RW.
Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder.
,
BMC psychiatry
[PubMed: 21281479]
[DOI: 10.1186/1471-244X-11-19]
Muneoka K; Shirayama Y; Takigawa M; Shioda S.
Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.
,
Neurochemical research
[PubMed: 18751896]
[DOI: 10.1007/s11064-008-9818-2]
Eckert L; Lan?on C.
Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons.
,
BMC psychiatry
[PubMed: 16867188]
[DOI: 10.1186/1471-244X-6-30]
<
1
2
3
...
11
12
>